To assess the relevance of tumor tissue expression of OSM and IL-6 in the context of invasive ductal carcinoma (IDC) patient survival, we used the Curtis Breast dataset obtained from OncomineTM [47]. Here, IL6 is linked to invasive ductal breast carcinoma.